About Ajinomoto Bio-Pharma Services

Website
Website
Employees
Employees
501-1,000 employees View all
Industry
Industry
biotechnology
Location
Location
San Diego, California, US
Description
Information
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs. Learn more: www.AjiBio-Pharma.com

Ajinomoto Bio-Pharma Services Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology

Frequently Asked Questions about Ajinomoto Bio-Pharma Services

What is Ajinomoto Bio-Pharma Services email format?

The widely used Ajinomoto Bio-Pharma Services email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Ajinomoto Bio-Pharma Services customer service number?

To contact Ajinomoto Bio-Pharma Services customer service number in your country click here to find.


Who is the CEO of Ajinomoto Bio-Pharma Services?

Daigaku Hideura is the CEO of Ajinomoto Bio-Pharma Services.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more